A detailed history of Lazard Asset Management LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 27,744 shares of CLPT stock, worth $363,446. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,744
Previous 23,106 20.07%
Holding current value
$363,446
Previous $355,000 7.32%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$11.89 - $18.8 $55,145 - $87,194
4,638 Added 20.07%
27,744 $329,000
Q4 2024

Feb 14, 2025

BUY
$10.74 - $16.68 $101,310 - $157,342
9,433 Added 68.99%
23,106 $355,000
Q3 2024

Nov 14, 2024

BUY
$5.3 - $13.18 $72,466 - $180,210
13,673 New
13,673 $153,000

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $321M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.